| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $374K | +106.6% |
| R&D Expense | $17.1M | -16.9% |
| SG&A Expense | $9.3M | +5.3% |
| Operating Income | -$26.0M | +11.0% |
| Interest Expense | $2.0M | +104.5% |
| Net Income | -$27.3M | +10.0% |
| EPS (Basic) | -$1.52 | +19.1% |
| EPS (Diluted) | -$1.52 | +19.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.2M | -30.3% |
| Current Assets | $64.7M | -21.7% |
| Total Assets | $81.8M | -18.2% |
| Current Liabilities | $10.9M | +150.5% |
| Long-term Debt | $15.0M | +0.0% |
| Total Liabilities | $21.7M | +10.0% |
| Stockholders' Equity | $60.1M | -25.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.7M | +20.4% |
| Investing Cash Flow | -$15.0M | +0.0% |
| Financing Cash Flow | $729K | -99.2% |